Extra-pancreatic net (epnet)

Clinical trials for Extra-pancreatic net (epnet) explained in plain language.

Never miss a new study

Get alerted when new Extra-pancreatic net (epnet) trials appear

Sign up with your email to follow new studies for Extra-pancreatic net (epnet), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Cancer patients to continue promising treatments in major extension trial

Disease control By invitation only

This long-term extension study offers continued access to several cancer drugs—including cabozantinib, atezolizumab, and nivolumab—for up to 5,000 patients who benefited from them in earlier Exelixis-sponsored trials. The study focuses on monitoring safety and ongoing clinical be…

Matched conditions: EXTRA-PANCREATIC NET (EPNET)

Phase 3 • Sponsor: Exelixis • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Extra-pancreatic net (epnet)

Get alerted when new Extra-pancreatic net (epnet) trials appear

Cancer patients to continue promising treatments in major extension trial